These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Effects of the pro-inflammatory milieu on the dedifferentiation of cultured fibroblast-like synoviocytes. Choi HS; Ryu CJ; Choi HM; Park JS; Lee JH; Kim KI; Yang HI; Yoo MC; Kim KS Mol Med Rep; 2012 Apr; 5(4):1023-6. PubMed ID: 22294296 [TBL] [Abstract][Full Text] [Related]
63. Synovial expression of Th17-related and cancer-associated genes is regulated by the arthritis severity locus Cia10. Jenkins E; Brenner M; Laragione T; Gulko PS Genes Immun; 2012 Apr; 13(3):221-31. PubMed ID: 22048456 [TBL] [Abstract][Full Text] [Related]
64. Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases. Kameda H; Suzuki M; Takeuchi T Drug Target Insights; 2007; 2():239-47. PubMed ID: 21901078 [TBL] [Abstract][Full Text] [Related]
65. Genistein inhibit cytokines or growth factor-induced proliferation and transformation phenotype in fibroblast-like synoviocytes of rheumatoid arthritis. Zhang Y; Dong J; He P; Li W; Zhang Q; Li N; Sun T Inflammation; 2012 Feb; 35(1):377-87. PubMed ID: 21792602 [TBL] [Abstract][Full Text] [Related]
66. CIP2A expression is associated with synovial hyperplasia and invasive function of fibroblast-like synoviocytes in rheumatoid arthritis. Lee J; Park EJ; Hwang JW; Oh JM; Kim H; Bae EK; Choi YL; Han J; Ahn JK; Cha HS; Koh EM Rheumatol Int; 2012 Jul; 32(7):2023-30. PubMed ID: 21479604 [TBL] [Abstract][Full Text] [Related]
67. Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study. Moodley D; Mody GM; Chuturgoon AA Clin Rheumatol; 2010 Oct; 29(10):1099-105. PubMed ID: 20532936 [TBL] [Abstract][Full Text] [Related]
68. Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Neumann E; Riepl B; Knedla A; Lefèvre S; Tarner IH; Grifka J; Steinmeyer J; Schölmerich J; Gay S; Müller-Ladner U Arthritis Res Ther; 2010; 12(3):R83. PubMed ID: 20462438 [TBL] [Abstract][Full Text] [Related]
69. Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule. Stuhlmeier KM Wien Med Wochenschr; 2006 Nov; 156(21-22):563-8. PubMed ID: 17160372 [TBL] [Abstract][Full Text] [Related]
70. An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes. Li X; Makarov SS Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17432-7. PubMed ID: 17088540 [TBL] [Abstract][Full Text] [Related]
71. Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor. Kameda H; Ishigami H; Suzuki M; Abe T; Takeuchi T Clin Exp Immunol; 2006 May; 144(2):335-41. PubMed ID: 16634808 [TBL] [Abstract][Full Text] [Related]
72. Are fibroblasts involved in joint destruction? Pap T; Meinecke I; Müller-Ladner U; Gay S Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv52-4. PubMed ID: 16239388 [No Abstract] [Full Text] [Related]
73. [Pathogenesis of RA: more than just immune cells]. Müller-Ladner U; Pap T Z Rheumatol; 2005 Sep; 64(6):396-401. PubMed ID: 16184347 [TBL] [Abstract][Full Text] [Related]
74. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis. Yamanishi Y; Boyle DL; Green DR; Keystone EC; Connor A; Zollman S; Firestein GS Arthritis Res Ther; 2005; 7(1):R12-8. PubMed ID: 15642132 [TBL] [Abstract][Full Text] [Related]
75. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Schedel J; Distler O; Woenckhaus M; Gay RE; Simmen B; Michel BA; Müller-Ladner U; Gay S Ann Rheum Dis; 2004 Oct; 63(10):1205-11. PubMed ID: 15361372 [TBL] [Abstract][Full Text] [Related]
76. Functional analysis of an arthritogenic synovial fibroblast. Aidinis V; Plows D; Haralambous S; Armaka M; Papadopoulos P; Kanaki MZ; Koczan D; Thiesen HJ; Kollias G Arthritis Res Ther; 2003; 5(3):R140-57. PubMed ID: 12723986 [TBL] [Abstract][Full Text] [Related]
77. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Kriegsmann J; Berndt A; Hansen T; Borsi L; Zardi L; Bräuer R; Petrow PK; Otto M; Kirkpatrick CJ; Gay S; Kosmehl H Rheumatol Int; 2004 Jan; 24(1):25-33. PubMed ID: 12712258 [TBL] [Abstract][Full Text] [Related]
78. p53 in rheumatoid arthritis: friend or foe? Müller-Ladner U; Nishioka K Arthritis Res; 2000; 2(3):175-8. PubMed ID: 11094424 [TBL] [Abstract][Full Text] [Related]
79. Gene therapy in rheumatoid arthritis: how to target joint destruction? Pap T; Müller-Ladner U; Gay R; Gay S Arthritis Res; 1999; 1(1):5-9. PubMed ID: 11094406 [No Abstract] [Full Text] [Related]
80. The p53 status in juvenile chronic arthritis and rheumatoid arthritis. Taubert H; Thamm B; Meye A; Bartel F; Rost AK; Heidenreich D; John V; Brandt J; Bache M; Würl P; Schmidt H; Riemann D Clin Exp Immunol; 2000 Nov; 122(2):264-9. PubMed ID: 11091284 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]